Kerri Fitzgerald

DocwireNews

According to a study published in JAMA Oncology, <a href="https://www.docwirenews.com/abstracts/mortality-after-breast-cancer-among-survivors-of-childhood-cancer-a-report-from-the-childhood-cancer-survivor-study/">premature deaths from cancer</a> cost the U.S. economy more than $94 billion in annual lost earnings. The authors say these findings &ldquo;suggest the potential for substantial financial benefit through delivery of effective <a href="https://www.docwirenews.com/abstracts/hem-onc-abstracts/an-overview-of-cancer-drugs-approved-by-the-us-food-and-drug-administration-based-on-the-surrogate-end-point-of-response-rate/">cancer prevention</a>, screening, and treatment to minimize premature cancer mortality in all states.&rdquo;The researchers calculated person-years of life lost using the number of cancer deaths and life expectancy data in U.S. individuals aged 16 to 84 years who died from cancer in 2015. The annual median earnings in the United States were used to assign a monetary value for each person-years of life lost by age and sex. Cancer mortality and life expectancy data were obtained from the National Center for Health Statistics and annual median earnings were obtained from the U.S. Census Bureau&rsquo;s 2016 Current Population Survey&rsquo;s March Annual Social and Economic Supplement.https://twitter.com/CarrascalAlvaro/status/1147822757926842368<h2>Billions lost, disparity by state</h2>A total of 8,739,939 person-years of life lost were lost to cancer death, translating to lost earnings of $94.4 billion (95% CI, 91.7-97.3). For individual cancer sites, lost earnings were highest for lung cancer ($21.3 billion), followed by colorectal ($9.4 billion), female breast ($6.2 billion), and pancreatic ($6.1 billion) cancers.&ldquo;There is also large variation across states, reflecting disparities in the burden,&rdquo; according to the authors. Age-standardized lost earning rates per 100,000 were lowest in the west and highest in the south, ranging from $19.6 million (95% CI, 19.1-20.2) in Utah to $35.3 million (95% CI, 34.4-36.3) in Kentucky.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
While following the money may seem simplistic, it shows where resources can be found for improvement, premature dealt from cancer is a loss of wages but also loss of GDP! <a href="https://t.co/DAUFKnoLvN">https://t.co/DAUFKnoLvN</a>
&mdash; Bogda Koczwara &#127803;&#127803;&#127803; (@bogda_koczwara) <a href="https://twitter.com/bogda_koczwara/status/1148105186717470720?ref_src=twsrc%5Etfw">July 8, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Approximately 2.4 million person-years of life lost and $27.7 billion (95% CI, 26.9-28.5) in lost earnings (29.3% of total that occurred in 2015) would have been avoided in 2015 if all states had the same age-specific person-years of life lost or lost earning rates as Utah.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Cancer Deaths Associated With $94.4 Billion in Lost Annual Earnings to U.S. Economy

Oncology

According to a study published in JAMA Oncology, premature deaths from cancer cost the U.S. economy more than $94 billion in annual lost earnings. 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe